PharmaBoardroom

Peter Anastasiou – Executive VP & Head of North…

Industry veteran Peter Anastasiou, executive VP and head of North America for Danish CNS specialist Lundbeck, outlines the performance of Lundbeck’s…

Pharma Faces: Teresa Rodó, Head of Global Healthcare Operations,…

PharmaBoardroom recently sat down with Merck’s EVP and Head of Global Healthcare Operations, Teresa Rodó to unpack her important role within the…

Malaria Prevention Cannot be Allowed to Stall During the COVID-19…

As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr Benjamin Pretorius, managing director…

Russia First Mover in Approving COVID-19 Vaccine Amid Widespread…

Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities, the first such approval globally.…

When Health Policy Becomes Industrial Policy

In his latest piece, Brendan Shaw casts his eye over why those drawing up health policies need to start incorporating issues of industrial policy into…

Overcoming US Pricing & Reimbursement Challenges

Executives from ALK, Sanofi Genzyme and Novartis discuss how they are navigating pricing and reimbursement issues in the USA, home to the world’s…

Hong Kong Biotech IPOs since Listing Reform in April 2018

On 30 April 2018, Hong Kong Stock Exchange’s (HKEX’s) introduced a number of reforms to allow and support the listing of pre-profit biotech…

US Execs on Product Launch Strategies during COVID-19: Digital…

With COVID-19 having wreaked havoc on global operations, the pharma industry is understandably focused on leveraging its collective resources and…

Understanding the Value of Patient Engagement

Jessica Scott, Takeda’s head of R&D patient engagement, highlights how a better understanding of the value of patient engagement across the…

Ameet Mallik – EVP, Head of US, Novartis Oncology

Ameet Mallik, Executive VP and Head of Oncology for the US at Novartis Oncology highlights the company's culture of 'curious, inspired, and unbossed,'…

Alper Ureten – VP, General Manager for Biosimilars…

Alper Ureten, Amgen VP and General Manager, sits down with PharmaBoardroom to set out his ambitions and objectives for its Biosimilars Business Unit.…

Cancer in the USA: A Snapshot

In recent years the US has seen an overall decease in cancer deaths thanks to innovative medicines and treatments. However, much work remains to be…

Tagged with US